{"title":"Risk factors and clinical outcomes in patients with colistin-resistant Klebsiella pneumoniae bloodstream infection: A retrospective analysis","authors":"Rimjhim Kanaujia , Imola Jamir , Navneet Arora , Manisha Biswal , Navneet Sharma , Pallab Ray , Ashok Kumar Pannu , Archana Angrup","doi":"10.1016/j.ijmmb.2025.100882","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Increase in the incidence of colistin-resistant <em>K. pneumoniae</em> (ColR) necessitates the study of risk factors responsible for its emergence. The current study aims to investigate the risk factors and clinical outcomes in ColR patients.</div></div><div><h3>Material and methods</h3><div>A retrospective study was conducted at a tertiary care hospital in India over 18 months (March 2021 to August 2022). We included patients >18 years (41 male, 38 female), with ColR and colistin-intermediate (ColI) strains. These patients were assessed for demographics, underlying diseases, antimicrobial treatment, clinical scores (APACHE II, SOFA), and outcome.</div></div><div><h3>Results</h3><div>The presence of a central venous catheter (CVC) was a significantly associated risk factor for ColR infections (p = 0.011). Additionally, prior antibiotic exposure within 3 months (p = 0.049) and CVC presence (p = 0.034) were associated with non-survival among ColR patients. Higher APACHE II and SOFA scores were associated with mortality among ColI patients. The presence of CCI >3 (p = 0.040) and previous history of ICU stay (p = 0.032) emerged as significant factors associated with the isolation of ColR <em>K. pneumoniae</em> among patients with previous history of colistin/polymyxin intake.</div></div><div><h3>Conclusion</h3><div>The study highlights the risk factors associated with ColR <em>K. pneumoniae.</em> These findings underscore the need for prudent antimicrobial stewardship.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"56 ","pages":"Article 100882"},"PeriodicalIF":1.4000,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Medical Microbiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0255085725000957","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
Increase in the incidence of colistin-resistant K. pneumoniae (ColR) necessitates the study of risk factors responsible for its emergence. The current study aims to investigate the risk factors and clinical outcomes in ColR patients.
Material and methods
A retrospective study was conducted at a tertiary care hospital in India over 18 months (March 2021 to August 2022). We included patients >18 years (41 male, 38 female), with ColR and colistin-intermediate (ColI) strains. These patients were assessed for demographics, underlying diseases, antimicrobial treatment, clinical scores (APACHE II, SOFA), and outcome.
Results
The presence of a central venous catheter (CVC) was a significantly associated risk factor for ColR infections (p = 0.011). Additionally, prior antibiotic exposure within 3 months (p = 0.049) and CVC presence (p = 0.034) were associated with non-survival among ColR patients. Higher APACHE II and SOFA scores were associated with mortality among ColI patients. The presence of CCI >3 (p = 0.040) and previous history of ICU stay (p = 0.032) emerged as significant factors associated with the isolation of ColR K. pneumoniae among patients with previous history of colistin/polymyxin intake.
Conclusion
The study highlights the risk factors associated with ColR K. pneumoniae. These findings underscore the need for prudent antimicrobial stewardship.
期刊介绍:
Manuscripts of high standard in the form of original research, multicentric studies, meta analysis, are accepted. Current reports can be submitted as brief communications. Case reports must include review of current literature, clinical details, outcome and follow up. Letters to the editor must be a comment on or pertain to a manuscript already published in the IJMM or in relation to preliminary communication of a larger study.
Review articles, Special Articles or Guest Editorials are accepted on invitation.